Craig Eagle
Vermogen: 10 M $ op 31-05-2026
Vermogen: 10 M $ op 31-05-2026
Craig Eagle bekleedt de functie van Chief Medical Officer bij Guardant Health, Inc. Hij zit ook in de raad van bestuur van 5 andere bedrijven. Voordien bekleedde hij de functie van VP-Strategic Alliances & Partnerships bij Pfizer Inc. en Vice President-Medical Affairs Oncology bij Genentech, Inc. Craig Eagle behaalde een doctoraat aan de Universiteit van New South Wales.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 73.403 ( 0,06% ) | 10 M $ | 31-05-2026 | |
| 04-04-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Directeur/Bestuurslid | 21-11-2017 |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Directeur/Bestuurslid | - |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic development and laboratory service company | Directeur/Bestuurslid | - |
MyMD Pharmaceuticals (Florida), Inc.
MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Directeur/Bestuurslid | 16-04-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| GUARDANT HEALTH, INC. | Hoofd Techniek/Wetenschap/O&O | 08-05-2026 |
| TELOMIR PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 14-11-2025 |
| Q/C TECHNOLOGIES, INC. | Directeur/Bestuurslid | 20-05-2025 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2021 |
| PFIZER INC. | Corporate Officer/Principal | 01-01-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and commercialization of drug delivery systems & technologies | Commercial Services |
Regenicin, Inc.
Regenicin, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company specializing in developing regenerative cell therapies | Health Technology |
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products and vaccines for the treatment of cancer diseases | Health Technology |
The University of New South Wales
The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assured Pharmacy, Inc.
Assured Pharmacy, Inc. Drugstore ChainsRetail Trade Owns and operates pharmacies | Retail Trade |
MyMD Pharmaceuticals (Florida), Inc.
MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Health Technology |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic development and laboratory service company | Health Services |
MyMD Pharmaceuticals, Inc.
MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau